Clinical Trial Update: Safety and Efficacy of CAR T Cell Therapy in Patients with R/r B-ALL [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 clinical trial is evaluating the safety and efficacy of an unnamed CAR T cell therapy in patients with relapsed or refractory B-cell acute lymphobla…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• B-cell Acute Lymphoblastic Leukemia

Drugs mentioned

• CAR-T cell therapy

Snippet

Sponsor: Kara Yakhteh Tajhiz Azma Company | Conditions: Relapse/Refractory B-cell Acute Lymphoblastic Leukemia | Phase 1, Phase 2 | Status: RECRUITING